Preview

Rational Pharmacotherapy in Cardiology

Advanced search

THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE

https://doi.org/10.20996/1819-6446-2014-10-3-307-311

Full Text:

Abstract

Some aspects of prevention of thromboembolic events in patients with atrial fibrillation, in particular, the use of implantable left atrial appendage occluding devices are discussed. Along with the literature review on this issue, the results of authors own experience of left atrial appendage occluding devices implantation is presented.

About the Authors

K. V. Davtyan
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


O. N. Tkacheva
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


A. A. Kalemberg
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


S. N. Koretsky
State Research Centre for Preventive Medicine
Russian Federation
Petroverigsky per. 10, Moscow, 101990 Russia


References

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: Framingham Study. Stroke 1991;22:983-8.

2. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillations in Olmsted country, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-25.

3. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. NEJM 2011;365:883-91.

4. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. NEJM 2011;365:981-92.

5. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEJM 2009;361:1139-51.

6. Levi MM, Eerenberg E, Löwenberg E, Kamphuise PW. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth J Med 2010;68(2):68-76.

7. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61(2):755-9.

8. Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta medica Scandinavica 1969;185:373-9.

9. Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-9.

10. Camm JA, Colombo A, Corbucci G, Padeletti L. Left atrial appendage closure: a new technique for clinical practice. Heart Rhythm 2014;11(3):514-21.

11. Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123(4):417-24.

12. Hughes S. PREVAIL Yanked From ACC Program; Watchman Device Meets Safety End Point. Availale at: http://www.medscape.com/viewarticle/780535. Accessed by 20.06.2014.

13. Park JW. Amplatzer Cardiac Plug Post-Market Registry Interim Results. Frankfurt: CSI; 2011;

14. Walsh K. Left atrial appendage closure with the Amplatzer Cardiac Plug: results of the European Prospective Observational Study. Paper presented at: EuroPCR 2012: Congress of the European Association of Percutaneous Cardiovascular Interventions. May 15-18, 2012; Paris, France.

15. Lam YY, Yip GW, Yu CM, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012;79:794-800.

16. Santoro G. Amplatzer Cardiac Plug: Italian Registry. Paper presented at: XIV International Symposium on Progress in Clinical Pacing 2010. November 30-December 3, 2010; Rome, Italy.

17. Guérios EE, Schmid M, Gloekler S, et al. Left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation. Arq Bras Cardiol 2012;98:528-36.

18. López-Minguez JR, Eldoayen-Gragera J, Gonzalez-Fernandez R, et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer Cardiac Plug. Rev Esp Cardiol 2013;66:90-7.

19. Ureña M, Rodes-Cabau J, Freixa X, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol 2013;62:96-102.

20. Kefer J, Vermeersch P, Budts W, et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol 2013; 68(6):551-8.

21. Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol 2013;61(25):2551-6.

22. Tzikas A, Karagounis L, Bouktsi M, Drevelegas Aet al. Left atrial appendage occlusion with the Amplatzer Amulet for stroke prevention in atrial fibrillation: the first case in Greece. Hellenic J Cardiol 2013;54(5):408-12. Поступила: 22.05.2014


For citation:


Davtyan K.V., Tkacheva O.N., Kalemberg A.A., Koretsky S.N. THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE. Rational Pharmacotherapy in Cardiology. 2014;10(3):307-311. (In Russ.) https://doi.org/10.20996/1819-6446-2014-10-3-307-311

Views: 596


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)